-
Salix Announces 2022 Gastrointestinal Health Scholars Program Winners
For Third Consecutive Year, 10 Pupils with Gastrointestinal Sickness Will Each and every Acquire a $10,000 Scholarship LAVAL, QC, July 13, 2022 /PRNewswire/ — Bausch Health and fitness Organizations Inc. (NYSE/TSX: BHC) (“Bausch Overall health”) and its gastroenterology business, Salix Pharmaceuticals, (“Salix”), just one of the greatest specialty pharmaceutical firms in the environment committed to the prevention and cure of gastrointestinal (GI) and liver disorders and issues, today announced the winners of its 2022 Salix Gastrointestinal Wellness Students Software. For the third consecutive year, Salix will be awarding $10,000 each to 10 learners dwelling with a GI ailment. “Salix is delighted to realize these 10 exceptional Salix Gastrointestinal Overall health Scholarship…